The Effect of Tucking on Semen Quality of Adult Trans Women
Launched by MEDICAL UNIVERSITY INNSBRUCK · Jul 29, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a practice called tucking, which some transgender women use to minimize bulging in their groin area, might affect their sperm quality. The researchers want to understand if tucking or wearing tight underwear contributes to lower sperm quality even before starting hormone therapy, which is known to potentially impact fertility. The study will include 40 transgender women aged 18 to 50 who are preparing to start hormone therapy. Half of them will be those who practice tucking, while the other half will not.
Participants can expect to provide semen and blood samples to assess their sperm quality and overall health at the beginning of the study. After a period of abstaining from tucking, they will provide more samples to see if there are any changes. Additionally, they will have the option to preserve their sperm for future use if they wish. This study is important because it aims to clarify the relationship between tucking and sperm quality, helping transgender women make informed choices about their fertility before starting hormone therapy.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Female transgender patients between the ages of 18 to 50 years of age who are seen at the University Clinic for Gyn. Endocrinology and Reproductive Medicine of the Medical University of Innsbruck. Patients must have met the eligibility and readiness criteria for gender-affirming hormone therapy
- Exclusion Criteria:
- • Ongoing GAHT gender affirming genital surgery Hypogonadism Diabetes mellitus Cystic Fibrosis Varicocele Cryptorchism Post-sterilization Incapacity to consent
About Medical University Innsbruck
The Medical University of Innsbruck is a leading academic institution dedicated to advancing healthcare through innovative research and clinical excellence. Situated in the heart of the Austrian Alps, it combines a rich tradition of medical education with cutting-edge scientific inquiry. As a prominent sponsor of clinical trials, the university focuses on a broad spectrum of medical fields, emphasizing the translation of research findings into practical applications for patient care. With a commitment to ethical standards and rigorous methodologies, the Medical University of Innsbruck strives to enhance treatment options and improve health outcomes globally through its collaborative efforts in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Innsbruck, , Austria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported